Guardant Health Eclipse Test

Listing Websites about Guardant Health Eclipse Test

Filter Type:

Guardant Health announces positive results from pivotal ECLIPSE …

(7 days ago) WEB- The test demonstrated 83% sensitivity for the detection of colorectal cancer with specificity of 90% - Results pave the way for first potential FDA-approved …

https://investors.guardanthealth.com/press-releases/press-releases/2022/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/default.aspx

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(9 days ago) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.businesswire.com/news/home/20221215006055/en/Guardant-Health-announces-positive-results-from-pivotal-ECLIPSE-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer

Category:  Health Show Health

Guardant Health Initiates ECLIPSE Pivotal Study for its LUNAR-2 …

(2 days ago) WEBGuardant Health, Inc. has initiated the ECLIPSE trial, a 10,000-patient registrational study to evaluate the performance of its LUNAR-2 blood test to detect colorectal cancer …

https://www.guardanthealthamea.com/guardant-health-initiates-eclipse-pivotal-study-for-its-lunar-2-blood-test-for-colorectal-cancer-screening/

Category:  Cancer Show Health

Guardant Health Reaches Target Enrollment of 12,750 Patients in …

(4 days ago) WEBTopline Data Release from ECLIPSE Planned for Mid-2022 Subject to Positive Study Outcome, Data Will Support a Premarket Approval (PMA) Submission to …

https://investors.guardanthealth.com/press-releases/press-releases/2021/Guardant-Health-Reaches-Target-Enrollment-of-12750-Patients-in-ECLIPSE-Pivotal-Study-for-its-LUNAR-2-Blood-Test-to-Detect-Colorectal-Cancer/default.aspx

Category:  Health Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(Just Now) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://finance.yahoo.com/news/guardant-health-eclipse-study-data-210000399.html

Category:  Health Show Health

Guardant Health Announces Shield™ Blood Test - Business Wire

(1 days ago) WEBThis year Guardant Health plans to share results of the ECLIPSE clinical study (NCT04136002) to demonstrate the performance of the Shield test to detect early …

https://www.businesswire.com/news/home/20220502005342/en/Guardant-Health-Announces-Shield%E2%84%A2-Blood-Test-Available-in-US-to-Detect-Early-Signs-of-Colorectal-Cancer-in-Average-Risk-Adults

Category:  Health Show Health

Buy Rating Affirmed for Guardant Health Amid Strong Shield Test

(7 days ago) WEBThe ECLIPSE study’s results showcasing the Shield test’s high sensitivity and specificity for colorectal cancer detection, as published in the New England Journal …

https://markets.businessinsider.com/news/stocks/buy-rating-affirmed-for-guardant-health-amid-strong-shield-test-prospects-and-positive-eclipse-study-results-1033164379

Category:  Cancer Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy of …

(3 days ago) WEBAbout the ECLIPSE study. ECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC …

https://markets.ft.com/data/announce/detail?dockey=600-202403131700BIZWIRE_USPRX____20240313_BW547689-1

Category:  Health Show Health

Guardant Health ECLIPSE Study Data Demonstrating Efficacy

(3 days ago) WEBECLIPSE is a prospective registrational study to evaluate the performance of Guardant Health’s blood test in detecting signs of CRC compared to a screening …

https://www.morningstar.com/news/business-wire/20240313547689/guardant-health-eclipse-study-data-demonstrating-efficacy-of-shield-blood-based-test-for-colorectal-cancer-screening-to-be-published-in-the-new-england-journal-of-medicine

Category:  Health Show Health

Guardant Health: Positive ECLIPSE Data Signals More Upside

(8 days ago) WEBThe upcoming approval of Guardant Shield (a convenient blood test) to detect the cumbersome and deadly colon cancer can be a game changer for both …

https://seekingalpha.com/article/4571170-guardant-health-positive-eclipse-data-signals-more-upside

Category:  Cancer Show Health

Guardant Health announces positive results from pivotal ECLIPSE …

(Just Now) WEBGuardant Health announces positive results from pivotal ECLIPSE study evaluating a blood test for the detection of colorectal cancer. 505 Penobscot Drive …

https://sitemaps.guardanthealth.com/2022/12/15/guardant-health-announces-positive-results-from-pivotal-eclipse-study-evaluating-a-blood-test-for-the-detection-of-colorectal-cancer/

Category:  Cancer Show Health

Guardant Health ECLIPSE study data - selectscience.net

(1 days ago) WEBGuardant Health, Inc., a leading precision oncology company, has announced the results from the ECLIPSE study that show the effectiveness of its …

https://www.selectscience.net/industry-news/eclipse-study-demonstrates-efficacy-of-shield-blood-based-test-for-colorectal-cancer-screening/?artID=60892

Category:  Health Show Health

Guardant preps for FDA review of colorectal cancer blood test

(9 days ago) WEBGuardant Health has its sights set on redefining how people get checked for colorectal cancer, and its blood test for catching stray tumor DNA soon has a date with …

https://www.fiercebiotech.com/medtech/guardant-health-preps-fda-advisory-panel-review-its-blood-based-colorectal-cancer-screening

Category:  Cancer Show Health

Guardant Health, Inc. - Guardant Health Reports First Quarter 2024

(1 days ago) WEBRevenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision …

https://investors.guardanthealth.com/press-releases/press-releases/2024/Guardant-Health-Reports-First-Quarter-2024-Financial-Results-and-Increases-2024-Revenue-Guidance/default.aspx

Category:  Health Show Health

Guardant Health Reports First Quarter 2024 Financial Results and

(3 days ago) WEBPALO ALTO, Calif., May 09, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended …

https://finance.yahoo.com/news/guardant-health-reports-first-quarter-200500610.html

Category:  Health Show Health

Guardant (GH) Gears Up for Q1 Earnings: Here's What to Expect

(1 days ago) WEBGuardant Health GH is scheduled to report first-quarter 2024 results on May 9, after market close. In the last reported quarter, the company’s earnings missed expectations …

https://www.msn.com/en-us/money/topstocks/guardant-gh-gears-up-for-q1-earnings-heres-what-to-expect/ar-BB1lYFUv

Category:  Health Show Health

Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript

(6 days ago) WEBGuardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ETCompany Participants. Helmy Eltoukhy - Chairman & Co-Chief …

https://seekingalpha.com/article/4691776-guardant-health-inc-gh-q1-2024-earnings-call-transcript

Category:  Health Show Health

Guardant Health Reports First Quarter 2024 Financial Results and

(8 days ago) WEBGuardant Health now expects full year 2024 revenue excluding screening to be in the range of $675 to $685 million, representing growth of 20% to 21% compared …

https://www.morningstar.com/news/business-wire/20240508447130/guardant-health-reports-first-quarter-2024-financial-results-and-increases-2024-revenue-guidance

Category:  Health Show Health

Earnings call: Guardant Health reports robust growth in Q1 2024

(4 days ago) WEBGuardant Health's total revenue grew by 31% to $168.5 million in Q1 2024. Clinical test volume increased by 20% year-over-year, with Guardant360 driving growth. …

https://www.investing.com/news/stock-market-news/earnings-call-guardant-health-reports-robust-growth-in-q1-2024-93CH-3435501

Category:  Health Show Health

Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance …

(Just Now) WEBGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing …

https://markets.businessinsider.com/news/stocks/guardant-health-receives-buy-rating-on-strong-q1-performance-and-positive-financial-outlook-1033371016

Category:  Health Show Health

Northern Lights Are Visible as Solar Storm Intensifies: What to …

(5 days ago) WEBA dramatic blast from the sun set off the highest-level geomagnetic storm in Earth’s atmosphere on Friday that is expected to make the northern lights visible as far …

https://www.nytimes.com/2024/05/10/science/solar-storm-earth.html

Category:  Health Show Health

Filter Type:

Filter By Time

Popular Searched

 › Belmont behavioral health philadelphia pa

 › Act of mental health no 106

 › World health organization regional office

 › Indian health service medical student

 › Genesis health care in columbia

 › World health organization translation guidelines

 › Kern family health care prescription formulary

 › Lamar county texas health department restaurant inspections

 › World health organization covid testing map

 › World health organization evipnet

 › World health organization impact

 › World health organization authorization form

 › Geneva world health organization translation

 › World health organization authorization request

 › World health organization translated

Recently Searched

 › Capital health primary bordentown nj

 › What is a single payer health care system

 › Public health preparedness pdf

 › Six domains of health

 › Guardant health eclipse test

 › National general accident and health provider

 › Kff health insurance rates 2022

 › Community health worker ethics

 › Healthiest energy drinks list

 › Intercare community health network jobs

 › Organized health care arrangement ocr

 › Mental health support pets

 › Ayush treatment in health care

 › Sample contract agreement for virtual mental health

 › Behavioral health provider expense